跳至主要内容
临床试验/IRCT20220723055530N1
IRCT20220723055530N1已完成2 期

Evaluation of the Safety and Effectiveness of Inovo Sense Smile and Inovo Sense Style Intradermal Injectable Gel for Correcting Moderate to Severe Nasolabial Folds

Khosro Medisa Teb Company0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • 30 -65 Years old men and women with moderate to severe nasolabial folds
  • Signing the informed consent form

排除标准

  • History of a cosmetic procedure in the lower 2/3 of the face during the last three months
  • Previous allergy to Hyaluronic Acid or Lidocaine
  • Presence of inflammation, active infection, unhealed old wound, and skin lesions in the NLF region
  • People prone to hypertrophic scar formation
  • History of autoimmune or immune deficiency diseases
  • Pregnancy or breastfeeding

研究者

发起方
Khosro Medisa Teb Company

相似试验